UnitedHealth’s Last Bear Stands Pat After Medicare Rate Hike
By Angel Adegbesan and Avalon Pernell | April 10, 2026
UnitedHealth Group Inc. experienced its best week in seven months following a surprising increase in Medicare Advantage payment rates for 2027, yet the company’s last remaining bearish analyst remains steadfast in his cautious stance.
The healthcare giant’s stock surged nearly 10%, with the bulk of gains occurring on Tuesday after the U.S. government announced a 2.48% hike in Medicare Advantage payments. This move came as a surprise since the initial government proposal had suggested that these rates would remain largely unchanged.
Medicare Advantage, a private health insurance option for Medicare beneficiaries, represents a significant revenue source for UnitedHealth. The upward revision in payments is expected to positively impact the company’s financial outlook, boosting investor confidence and contributing to the stock rally.
Despite this favorable development, one analyst—UnitedHealth’s last known skeptic—continues to maintain a bearish perspective on the stock, suggesting caution amid market optimism. This individual’s conviction highlights ongoing debates within the investment community regarding the long-term sustainability of growth for UnitedHealth and the broader Medicare Advantage market.
The stock’s rally reflects how policy changes can swiftly influence market sentiment, especially in sectors such as healthcare where government reimbursement rates play a pivotal role. Investors will be closely monitoring how UnitedHealth capitalizes on this regulatory shift in the coming quarters.
For more details or to provide news feedback, Bloomberg encourages readers to contact their reporters or utilize the provided feedback channels.
Photo caption: UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange (NYSE). Photographer: Michael Nagle/Bloomberg